Accumulation of Depressive Symptoms and Carotid Intima-Media Thickness : the Cardiovascular Risk in Young Finns Study by Keltikangas-Järvinen, Liisa et al.
Depressive symptoms and IMT
1
This is an Accepted Manuscript of an article published by Springer in Annals of Behavioral
Medicine. The final publication is available at link.springer.com via http://dx.doi.org/
10.1007/s12160-017-9884-2
Liisa Keltikangas-Järvinen, PhD1, Kateryna Savelieva, MA1, Kim Josefsson, PhD2,
Marko Elovainio, PhD1,2, Laura Pulkki-Råback, PhD3,1, Markus Juonala, MD, PhD4,
Olli T. Raitakari, MD, PhD5, and Mirka Hintsanen, PhD6,1* (2017). Accumulation of
Depressive Symptoms and Carotid Intima-Media Thickness: the Cardiovascular Risk in
Young Finns Study. Annals of Behavioral Medicine 51(4), 620-628. doi: 10.1007/s12160-
017-9884-2
1Institute of Behavioural Sciences, University of Helsinki, Helsinki, Finland;
2National Institute for Health and Welfare, Helsinki, Finland;
3Helsinki Collegium for Advanced Studies, University of Helsinki, Finland;
4Department of Medicine, University of Turku, Turku, Finland, Division of Medicine, Turku
University Hospital, Turku, Finland, and Murdoch Childrens Research Institute, Parkville,
Victoria, Australia;
5Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku,
Turku, Finland and Department of Clinical Physiology and Nuclear Medicine, Turku
University Hospital, Turku, Finland;
6Unit of Psychology, Faculty of Education, University of Oulu, Oulu, Finland
*Correspondence: Mirka Hintsanen, P.O. Box 2000, 90014 University of Oulu, Oulu,
Finland. Phone: +358 50 569 5243 and e-mail: mirka.hintsanen@oulu.fi.
Depressive symptoms and IMT
2
Accumulation of Depressive Symptoms and Carotid Intima-Media Thickness: the
Cardiovascular Risk in Young Finns Study
Background: The association between depressive symptoms and subclinical atherosclerosis
has been inconsistent. Purpose: We sought to replicate our previous study, which
demonstrated positive relation between depressive symptoms and subclinical atherosclerosis
assessed with carotid intima-media thickness (IMT) in men, using newer measurement of
carotid IMT and a cumulative loading of depressive symptoms over three follow-ups.
Methods: The sample comprised 996 adults (352 men) aged 30 to 45 years in 2007 from a
prospective population-based Finnish sample. The participants completed a modified version
of Beck Depression Inventory in 1992, 1997, and 2001. Carotid IMT was assessed with
ultrasound in 2001 and 2007. Cardiovascular risk factors (i.e., body mass index, systolic
blood pressure, low-density lipoprotein cholesterol, and smoking) were measured in
childhood (1980) and in adulthood (2007). Results: We found no association between
accumulative depression index and carotid IMT before or after controlling for the traditional
risk factors (all ps ≥ 0.67). Depressive symptoms did not predict IMT progression over two
time points and the highest level of carotid wall thickening. Imputed and non-imputed
datasets provided similar results. Results remained the same when men and women were
analyzed separately. Additional analyses revealed no significant interactions between
depressive symptoms and cardiovascular risk factors (i.e., body mass index and systolic blood
pressure) on carotid IMT (all ps > 0.15). Conclusions: The findings of this population-based
study did not indicate any direct association between depressive symptoms and carotid IMT
in asymptomatic, young adults.
Key words: atherosclerosis, carotid intima-media thickness, depression, psychosomatic.
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Since the mid-1980s, depression has been seen to play an important role in a behavioral
pathogenesis of coronary heart disease (CHD) (1), even so that in 1999 Hemingway and
Marmot named depression one of the four most evident behavioral risk factors of CHD (2).
They concluded that in an aetiology and prognosis of CHD, from several behavioral risk
factors depression and anxiety, hostility, work stress, and social support have been given the
most stable and established roles by previous prospective studies (2). Since then, conflicting
findings have increased (1,3,4) questioning at least a general pathogenic role of depression,
i.e., a suggestion that depression plays an equal role in clinical and in healthy populations, as
well as in different stages of CHD process being correlated both with preclinical stages like
atherosclerosis and a progression and development of a diagnosed CHD.
Considerable evidence suggests that depression is highly prevalent in cardiac patients
(5,6). One in five patients with CHD is depressed, which is at least 3 times greater than in the
general population (6). However, a role of depression in subclinical stages of CHD in
asymptomatic, healthy samples is less clear. Findings have been especially inconsistent
regarding the thickness of the common carotid artery intima-media complex (IMT), which is
widely used as a surrogate marker of carotid atherosclerosis (7,8). Both positive relationships
(9–12) and null findings (13–17) have been documented. With few exceptions (18), the
general pattern of findings has been that depressive symptoms are positively associated with
increased IMT in people over the age of 50 (9,10,19–21); whereas no association was found
for younger participants (22,23) or a combination of younger and older people (13,14).
Moreover, the majority of positive findings have exclusively relied on an assessment of
depressive symptoms at a single time point. Given that the relationship between depression
and carotid IMT is not static (14), examining the chronic or recurrent depression in relation to
IMT might help to reduce inconsistencies in the literature. In addition, in those studies,
variations of study design, ultrasound protocols, definition of depression, and age of
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participants may account for discrepancies in findings. Therefore, following the same
participants in the same frame of reference would be needed to decrease the abovementioned
potential sources for inconsistent findings in the existing literature. This study was taken with
that purpose.
This study has several aims. First, we examine whether depressive symptoms from
several follow-up studies are recurrently associated with carotid IMT in initially healthy and
asymptomatic individuals. We have previously found a cross-sectional association between
depressive symptoms and carotid IMT but only in men (18). Now we ask whether these
results can be repeated in the same participants six years later. If our previous findings
maintain, an association should become stronger along with the aging of the sample. Second,
we investigate whether a cumulative loading of depressive symptoms from three
measurement points (i.e., an accumulative depression index) is linked to carotid IMT. Finally,
we explore whether a role of depressive symptoms varies at different risk levels of carotid
IMT and in IMT progression over two time points. Those issues were neither examined in our
previous study nor taken into account systematically in any previous studies.
Methods
Study population
The participants came from the Cardiovascular Risk in Young Finns Study (CRYFS),
a population-based follow-up study assessing cardiovascular risks from childhood into
adulthood. The original sample (N = 3,596, collected in 1980) included randomly selected
Finnish children and adolescents from six different age cohorts from 3 to 18 years. The design
of the study and the sample selection have been described in detail elsewhere (24).
Participants twelve years of age and older gave informed consent, and the parents gave
consent for younger participants. The study was approved by local ethics committees and
conducted in accordance with the Helsinki declaration.
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Procedure
The current study comprised the baseline examination in 1980 and follow-up
examinations in 1992, 1997, 2001 and 2007. At baseline, clinical measurements of
children/adolescent were conducted by trained staff who obtained measures of blood pressure,
weight and height, and also drew venous blood samples. In the 1992, 1997, and 2001 follow-
up studies, participants self-reported their depressive symptoms. In the 2001 and 2007 follow-
up studies, participants’ (30-45 years old in 2007) carotid IMT and cardiovascular risk factors
were assessed (along with other biomedical measures not relevant for the current study).
Participants with a diagnosed or self-reported diabetes or self-reported CHD (n = 48) were
excluded from the sample. Participants were also excluded if they had not answered at least
70% of the depression items each year. There were 2303, 2079, and 2072 participants who
had data for depressive symptoms in 1992, 1997, or 2001, respectively. There were 1302
participants who had data for depressive symptoms in all three measurements and 996 of
these had also complete data on carotid IMT and risk factors in 2007, which formed the
analytic sample of the current study. Compared with the eligible sample at the baseline of the
CRYFS, the participants in the present study were more often female (64.7% vs. 45.7%, χ² (1)
= 103.15, p < 0.001). Differences in other childhood/adolescence baseline characteristics were
minimal and statistically nonsignificant (all ps > 0.30).
Measures
Depressive symptoms. Depressive symptoms were assessed using a modified version
of the Beck Depression Inventory (mBDI). The original version of the BDI (25) offers 4
alternative statements of 21 items ranging from minimal to severe symptoms of depression
(e.g., (0) “I do not feel sad”, (1) “I feel sad”, (2) “I am sad all the time and I cannot snap out
of it”, (3) “I am so sad or unhappy that I cannot stand it”). In the present study, the
participants were asked to rate the second mildest descriptions of the original 21 items (e.g.,
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“I often feel sad”) on a five-point scale ranging from totally disagree (1) to totally agree (5).
Originally, these second mildest items were selected because they were suggested to measure
depressive symptoms more accurately among the normal population than corresponding
clinical scales (26). Previous research supports this assumption (27,28). It has been reported
that the modified version of BDI is highly correlated with original BDI-II (r = .77) (27). Scale
reliability of the mBDI was 0.89 in 1992, 0.91 in 1997, and 0.92 in 2001. The mean score of
all the 21 items formed the general depression index each year. To capture the accumulative
effect of depressive symptoms in the general population, these three depressive indexes were
summed together. The accumulative depression index was used as a continuous variable in all
main analyses (ranged 3.10-11.46) in order not to lose any information by categorization. The
sensitivity analyses were conducted using accumulative depression index as a dichotomous
variable (i.e., a multiple depressive symptoms group and a fewer depressive symptoms
group). Three cutoff points were applied for accumulative depression index: participants in
highest 10% of the sample distribution, in highest 20%, and using median split.
Carotid IMT. Ultrasound studies in the present study were performed in 2001 and
2007 using Sequoia 512 ultrasound mainframes with 13.0-MHz linear array transducers. The
left carotid artery was scanned by ultrasound technicians following a standardized protocol
(29). In brief, a magnified image was recorded of the angle showing the greatest distance
between the lumen-intima interface and the media-adventitia interface. A moving scan
(duration 5 seconds) that included the beginning of the carotid bifurcation and the common
carotid artery was recorded and stored in digital format on optical discs for subsequent off-
line analysis. The digitally stored scans were manually analyzed by a single reader who was
blinded to subjects’ details. The analyses were performed using ultrasound calipers. From the
5-second clip image, the best quality end-diastolic frame was selected (incident with the R-
wave on a continuously recorded electrocardiogram). From this image, at least four
Depressive symptoms and IMT
7
measurements of the common carotid wall were taken approximately 10 mm proximal to the
bifurcation in order to derive mean carotid IMT. A 6.4% between-visit coefficient and a 5.2%
between-observer coefficient of variation in the IMT measurements have been reported (29).
Six-year change in carotid IMT was calculated as mean carotid IMT from 2007 minus mean
carotid IMT from 2001. In agreement with prior research (30), we controlled for baseline
carotid IMT (from 2001) in all analyses where the outcome variable was carotid IMT
progression. To capture the severe thickening of a carotid wall, carotid IMT was divided into
quartiles based on the population distribution (31). High level of carotid wall thickening was
defined by assigning a point to the top 25% of the participants and 0 to all other participants.
Cardiovascular risk factors. The risk variables measured in childhood (in 1980)
included low-density lipoprotein (LDL) cholesterol, body mass index (BMI), and systolic
blood pressure. The risk factors measured in adulthood (2007) were LDL cholesterol, BMI,
systolic blood pressure, and smoking. These risk factors have been previously shown to
predict adult common carotid artery IMT in the same data set (29). Smoking status was
assessed by a questionnaire, and those smoking on a daily basis were classified as smokers.
BMI was calculated as weight in kilograms divided by the square of their height in meters.
Height was measured with a wall-stationed statiometer and weight with digital scales. All
measurements of lipid levels were performed in duplicate in the same laboratory.
Standardized enzymatic methods were used for measuring levels of serum total cholesterol,
triglycerides, and high-density lipoprotein cholesterol. The LDL cholesterol concentration
was calculated by the Friedewald formula (32). Blood pressure was measured with a standard
mercury sphygmomanometer in 1980 and with a random zero sphygmomanometer in 2007.
Details of the methods have been reported elsewhere (29).
Statistical analyses
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Main analyses. Linear regression analyses were used to examine the relationships
between accumulative depression index and carotid IMT. Interactions between sex and
depressive symptoms, as well as age and depressive symptoms on carotid IMT were analyzed,
but both appeared nonsignificant. Thus, these interactions were dropped from further
analyses. Two models were constructed: in Model 1, only sex and age were controlled for; in
Model 2, sex, age, and the cardiovascular risk factors from childhood and adulthood were
adjusted for. All analyses were first performed with carotid IMT in 2007 as the dependent
variable and then with IMT progression over 6 years. In addition, logistic regression analyses
were used to test the relationship between the accumulative depression index and the severe
thickening of a carotid wall. All analyses were also repeated separately for men and women,
as well as for older (aged 39-45 years in 2007) and younger (30-36 years old in 2007) age
groups. Finally, sensitivity analyses were conducted to examine whether high levels of
depressive symptoms (as indicated using three different cutoff points, such as participants in
top 10%, top 20%, and based on median split) contributed to the progression of
atherosclerosis.
We also examined whether depressive symptoms from the 1992, 1997, 2001, and
2007 follow-ups were associated with carotid IMT from 2007 separately for men and women.
Following the same procedure as previously applied (18), several regression models were
tested. First, carotid IMT was regressed on age and depressive symptoms from 1992, 1997,
2001, and 2007 in separate models. Second, age and depressive symptoms from 1992, 1997,
2001, and 2007 were entered as independent variables into the model simultaneously. Finally,
the cardiovascular risk factors from 1980 and 2007 along with depressive symptoms from
four time points were entered into the fully-adjusted regression model. We also repeated the
analyses using the dichotomous depression variables from each year. In order to be consistent
with our previous findings (18), we classified participants with the mean depression score in
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the highest 10% into the multiple depression group and others into a fewer depression group
in those analyses.
Supplementary analyses. We also conducted additional analyses to test whether the
absence of the association between depressive symptoms and IMT may be explained by
moderating effect of cardiovascular risk factors, which were associated with higher IMT.
Three separate linear regression models were applied first  to test the interactions between
accumulative depression index and adult BMI, as well as between accumulative depression
index and systolic blood pressure from childhood and adulthood on carotid IMT without any
adjustments; next adjusted for age and sex; and finally conducted separately for men and
women.
Multiple imputation by chained equations was done in STATA 13.1 (33) to estimate
missing values for participants with missing data in depressive symptoms and cardiovascular
risk factors. We calculated the main statistical analyses using the pooled estimates of 50
imputed data sets (n = 2,160).
All statistical analyses were calculated in STATA version 13.1.
Results
Table 1 shows the characteristics of the study participants. There were statistically
significant sex differences in adults’ low-density lipoprotein cholesterol, BMI, systolic blood
pressure, depressive symptoms, and carotid IMT (all ps < 0.001). Women were more
depressed on average compared to men (6.42 vs. 5.94, p < 0.001). In contrast, the LDL
cholesterol, BMI, and systolic blood pressure were significantly higher in men. To continue,
men also had higher carotid IMT than women in 2007 (0.63 vs. 0.61, p < 0.001). The data
about IMT progression was available for 915 participants. The bivariate correlation between
two measurements of carotid IMT (from 2001 and 2007) was r = 0.61, p < 0.001. The IMT
progression variable was normally distributed for both men and women with average scores
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0.05 mm (SD = 0.09) and 0.04 mm (SD = 0.08), respectively. The measurement error in the
IMT assessments was at least of similar size or even larger than the standard deviation of IMT
progression. Thus, the IMT progression assessment was diluted by measurement error which
makes finding significant associations quite unlikely. Despite this, IMT progression was
analyzed to examine all possible associations.
Table 2 presents the bivariate correlations between depressive symptoms and
cardiovascular risk factors. In men, only higher BMI in adulthood was related to
accumulation of depressive symptoms. In women, both higher BMI and smoking in adulthood
were associated with higher depressive symptoms. Neither carotid IMT nor IMT progression
was directly related to accumulative depressive symptoms in men or women.
No statistically significant associations were found between the accumulative
depression index and either carotid IMT or progression of carotid IMT over six years (Table
3). Correspondingly, the logistic regression analyses revealed no significant associations
between accumulative depression index and the higher level of carotid IMT (findings not
shown). The association was not significant before or after controlling for various
cardiovascular risk factors (BMI, systolic blood pressure, LDL-cholesterol, and smoking in
childhood and adulthood). Older age and male sex were robustly associated with higher
carotid IMT in all models (all ps < 0.001). Higher childhood systolic blood pressure and
increased BMI in adulthood were also related to higher level of carotid IMT (all ps < 0.01).
The results were the same when we additionally controlled for adult waist circumference in
order to take into account the participants’ gaining body fat. The findings also remained intact
when accumulative depression index was used in the sensitivity analyses as a dichotomous
variable (multiple symptoms depressive group was coded as highest 10%, 20%, and 50% of
the sample). All variations of these primary analyses also failed to yield meaningful
associations. No significant results were found when the analyses were conducted separately
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for men and women (Supplementary Table 1) or for older and younger age groups
(Supplementary Table 2). Moreover, when the initially excluded participants (n = 48) who
had a diagnosed or self-reported diabetes or self-reported CHD were included in the sample,
no significant differences were observed. Finally, the analyses with the imputed data also
failed to provide significant associations between depressive symptoms and carotid IMT, as
well as IMT progression (Supplementary Table 3) and the higher level of carotid IMT (data
not shown).
We also examined the link between depressive symptoms from 1992, 1997, 2001, and
2007 with carotid IMT separately for men and women. The relation between continuous
depressive symptoms scores from these years and carotid IMT were not statistically
significant in all models either for men or women. The high level of depressive symptoms
(highest 10%) in 1997 and 2001 were associated with carotid IMT only in men when
depressive symptoms from four follow-ups were entered into the model simultaneously
(depressive symptoms in 1997: unstandardized B = -0.07, p = 0.016; depressive symptoms in
2001: unstandardized B = 0.08, p = 0.003). The adjustment for additional cardiovascular risk
variables did not substantially alter this association (see Supplementary Table 4). The
analyses with the imputed data, however, revealed no statistically significant associations
between both continuous and dichotomous depressive symptoms scores and carotid IMT in
any models either for men or women (Supplementary Table 5).
Finally, no significant interactions between depressive symptoms and cardiovascular
risk factors (i.e., BMI and systolic blood pressure) on carotid IMT were found (all ps > 0.15).
The findings with the imputed data were similar to those in the complete data.
Discussion
Findings from this population-based cohort study do not provide an evidence for an
association between depressive symptoms and carotid IMT in healthy, asymptomatic
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individuals. Associations were nonsignificant before and after adjusting for traditional CHD
risk factors in childhood and adulthood. Neither linear relationships nor the relationships
between extremely high levels of accumulative depressive index and carotid IMT were found.
Cumulative score of depressive symptoms also failed to explain IMT progression over a
follow-up of 6 years. Several variations of the analyses (i.e., separation of men and women,
multiple imputation, and covariate removal) were not able to identify a reason for the lack of
expected results. This indicates that among healthy people under the age of fifty depressive
symptoms may not play any significant role in a pathogenesis of CHD.
Prior population-based studies have investigated the association between depression
and atherosclerosis, although evidence is controversial: some studies found the relationship
significant (10,19,34), while others did not (13,16,35). Overall, the systematic methodological
differences, such as different sample size, prospective or cross-sectional study designs, and
the way depression and carotid IMT were measured do not seem to account for the absence or
presence of a significant relationship between depression and atherosclerosis. In addition, we
were not able to replicate our previous findings (18) in older age cohorts and in other study
waves. Thus, we have to include our own positive result to the list of “random findings” as
well.
To the best of our knowledge, no previous study has systematically examined all
possible variants of an association between depressive symptoms and atherosclerosis, i.e.,
linear associations, associations in the extremes and in different sex groups, using the IMT
progression variable over 6 years, and cumulative score for depressive symptoms over a
follow-up period of 9 years. Although no evidence was found in our study, the findings
cannot falsify the role of depression in a pathogenesis of CHD. A recent review suggests that
depression is a non-causal risk marker for CHD, and that causality cannot be established (36).
According to this view, depression co-varies with some mechanisms leading to CHD but is
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not causally related to it. Therefore, it is possible that depression plays a role in the
pathogenesis of CHD through other parameters (e.g., behavioral or biological factors) by
making depressed patients more vulnerable to other cardiac risks (1). For example, depression
is associated with higher rates of harmful lifestyle habits, including unhealthy diet, reduced
exercise, and smoking (6). With respect to biological mechanisms, some evidence suggests
that depression is linked to inflammatory process (37), altered hypothalamic pituitary adrenal
hormones (38), autonomic nervous system dysregulations (39), and platelet dysfunction (40),
all of which are implicated in the pathogenesis of CHD. Moreover, time dynamics should be
also taken into account. Those individuals who were depressed early in life may be a selected
group who would have developed especially unhealthy lifestyles, which in turn would
increase their IMT. However, in this case the association between depression and IMT should
be attenuated if health behaviors were taken into account. This was not the case in our
previous study that found association between depression and IMT in men even though the
health behaviors were adjusted for (18). It should be noted that lifestyle may also have a
stronger impact with increasing age (41), whereas depression may play less important role
(42).
To continue, we should not exclude a role of depression for atherosclerosis in the
certain context (i.e., the effect of age). The considerable amount of studies have found an
association between depression and atherosclerosis in older populations (50 years of age and
older) (9,10,12,19–21,43). Although there was no relation between depressive symptoms and
carotid IMT in older participants (aged 39-45 years) in this study, it is possible that
atherosclerosis may be detectable relatively late in life. This may be a reason why studies with
younger participants (age 24-52) have not found an association (22,23). Finally, different
measurements of atherosclerosis may partly account for inconsistent findings in the literature.
Although carotid IMT is often considered as a surrogate marker of atherosclerosis, some
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evidence has suggested that carotid IMT reflects an adaptive response of the vessel wall to
changes in shear stress, lumen diameter, tensile stress, and pressure instead of an
atherosclerotic thickening (44). Some studies have shown that depression is related to plaque
(11,23) or coronary artery calcification (12), which are considered as more reliable predictors
of the atherosclerotic process than IMT (23,45).
Strengths and Limitations
Strengths of this study involve its populations-based sample, long follow-up period
over 27 years, longitudinal design with several measurements of depressive symptoms and
IMT, and the possibility to adjust for childhood cardiovascular risk factors, thereby
eliminating the confounding influence of baseline health. The accumulative depression index
based on three time points over 10 years ascertained to capture chronic or recurrent depressive
symptoms better than a measurement from a single point in time.
In interpreting these results, several limitations should be taken into account. As with
most longstanding studies, attrition in this follow-up study was considerable. To deal with the
possibility that selective drop-out would have biased our findings, we conducted analyses
using multiply imputed data, and the results were similar in most cases to those in the original
data. Furthermore, we were not able to define a clinically significant cutoff point for the high
level of depressive symptoms; therefore, we conducted several sensitivity analyses using
different cutoff points to detect any differences in the findings. Moreover, carotid IMT was
not measured at the baseline, therefore it is possible that there are common pathophysiological
processes behind the association between depressive symptoms and increased IMT. Finally,
the sample was mainly White Caucasian, which limits generalizability of our findings to
ethnically more diverse populations.
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Conclusions
In summary, the findings of this population-based study do not indicate any direct
association between depressive symptoms and atherosclerosis in asymptomatic, young adults.
This study, however, do not completely question a role of depression in a pathogenesis of
CHD, as it may co-vary with some mechanisms leading to CHD but is not causally related to
it.
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Table 1. Characteristics of the study participants (n = 996)
Men (n = 352) Women (n = 644)
Mean (SD) Range   Mean (SD) Range p-value
Age in 1980, years 10.2 (4.98)  3-18 10.8 (5.04)  3-18 0.106
Childhood risk factors
   LDL-cholesterol, mmol/l 3.3 (0.71)  1.09-6 3.4 (0.76) 1.62-7.55 0.079
   Body mass index, kg/m² 17.6 (2.95) 9.2-36.02 17.8 (2.83) 12.79-28.33 0.286
   Systolic blood pressure, mm Hg 112.9 (12.51) 78-164.67 111.8 (11.2)  68-140.67 0.175
Adulthood risk factors
   LDL-cholesterol, mmol/l 3.3 (0.83)  0.85-6.56 2.9 (0.72) 0.75-5.47 0.001
   Body mass index, kg/m² 26.3 (3.95) 17.54-45.89 25.2 (4.58) 16.56-47.33 0.001
   Systolic blood pressure, mm Hg 125.2 (12.21) 97-168.67 116.4 (13.28) 88-162.67 0.001
   Daily smokers (%) 16.8% 13.98% 0.239
Carotid IMT, mm 0.63 (0.11) 0.4-1.08 0.61 (0.09) 0.41-1.04 0.001
IMT progression, mm 0.05 (0.09)  -0.24-0.42 0.04 (0.08)  -0.20-0.29 0.069
Accumulative depression index 5.94 (1.57) 3.10-11.29   6.42 (1.61) 3.24-11.46 0.001
Note. LDL-cholesterol = low-density lipoprotein cholesterol, IMT = intima-media thickness
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Table 2. Correlation coefficients between childhood and adulthood risk factors and
accumulative depression index
Accumulative depression index
Complete cases Men Women
(n = 996)  (n = 352)  (n = 644)
Age in 1980, years  -0.02 -0.00 -0.04
Childhood risk factors
   LDL-cholesterol, mmol/l -0.1 -0.00 -0.03
   Body mass index, kg/m²    0.00 0.04 -0.03
   Systolic blood pressure, mm Hg  -0.04 -0.04 -0.04
Adulthood risk factors
   LDL-cholesterol, mmol/l -0.04 -0.2 -0.01
   Body mass index, kg/m²     0.10**    0.17**   0.10*
   Systolic blood pressure, mm Hg -0.02 0.04 0.02
   Daily smokers (%)     0.07** 0.05   0.09*
Carotid IMT, mm -0.01 0.01 0.01
IMT progression, mm 0.05 0.05 0.06
Note. ***p < .001, **p < .01, *p < .05
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Table 3. Unstandardized regression coefficients for accumulative depression index predicting carotid IMT and IMT progression, men
and women combined
Complete cases Carotid IMT Carotid IMT progression†
B (SE) 95% CI B (SE) 95% CI
Model 1
Age, years  0.007 (0.001)***    0.006, 0.008  0.004 (0.001)***  0.003, 0.005
Male sex  0.028 (0.006)***   0.016, 0.039  0.002 (0.005)***  0.009, 0.029
Accumulative depression index  0.001 (0.002)  -0.002, 0.005  0.002 (0.002)  -0.001, 0.005
Model 2
Age, years  0.005 (0.001)***   0.003, 0.007  0.003 (0.001)***  0.001, 0.004
Male sex  0.017 (0.006)**   0.005, 0.029  0.014 (0.005)*  0.003, 0.025
Childhood risk factors
   LDL-cholesterol, mmol/l  0.001 (0.004)  -0.008, 0.009  0.001 (0.004)  -0.007, 0.009
   Body mass index, kg/m^2  0.002 (0.001)  -0.001, 0.005  0.001 (0.001)  -0.001, 0.004
   Systolic blood pressure, mm Hg  0.001 (0.000)**   0.000, 0.001  0.001 (0.000)*   0.000, 0.001
Adulthood risk factors
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   LDL-cholesterol, mmol/l  0.003 (0.004)  -0.006, 0.011  0.005 (0.004)  -0.002, 0.013
   Body mass index, kg/m^2  0.004 (0.001)***   0.002, 0.005  0.002 (0.001)***   0.001, 0.004
   Systolic blood pressure, mm Hg  0.000 (0.000)  -0.000, 0.001  0.000 (0.000)  -0.000, 0.000
   Daily smoking  0.005 (0.007)  -0.010, 0.020  -0.001 (0.007)  -0.014, 0.013
Accumulative depression index  -0.000 (0.002)  -0.003, 0.003    0.002 (0.002)  -0.001, 0.005
Note. ***p < .001, **p < .01, *p < .05.
†Baseline carotid IMT (measured in 2001) was included into Model 1 and Model 2 as a control variable.
